Pharmicell Co

Pharmicell Co FCF per Share

The Free Cash Flow per Share of Pharmicell Co (005690.KS) as of Nov 7, 2026 is 559.90 KRW. In the previous year, Free Cash Flow per Share was -14.01 KRW — a change of -4,095.77% (higher).

FCF per Share

559.90KRW

YoY

-4,095.77%

Last updated:

Free Cash Flow per Share of Pharmicell Co is 2025 559.90 KRW. Free Cash Flow per Share of Pharmicell Co was 2024 -14.01 KRW. It decreases by -4,095.77% higher compared to the previous year.

The Pharmicell Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-21.23 KRW
Jan 1, 2019
-28.99 KRW
Jan 1, 2020
137.38 KRW
Jan 1, 2021
-159.18 KRW
Jan 1, 2022
-184.22 KRW
Jan 1, 2023
96.64 KRW
Jan 1, 2024
-14.01 KRW
Jan 1, 2025
559.90 KRW
The Pharmicell Co FCF per Share history
YEARFCF per ShareYoY
559.90KRW-4,095.77%
-14.01KRW-114.50%
96.64KRW-152.46%
-184.22KRW+15.73%
-159.18KRW-215.87%
137.38KRW-573.91%
-28.99KRW+36.57%
-21.23KRW-79.74%
-104.77KRW+119.43%
-47.75KRW-66.99%
-144.65KRW-26.61%
-197.10KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pharmicell Co Stock analysis

What does Pharmicell Co do? Pharmicell Co., Ltd. develops stem cell-based pharmaceuticals and technologies, focusing on stem cell therapeutic drugs and stem cell-based cosmetics. The company provides stem cell storage services and supplies mesenchymal stem cells (MSCs) for research purposes. It also operates a fashion business under the brand names Religion and Day, offering women’s and men’s apparel. The company merged with its wholly owned subsidiary on March 31, 2013, which was primarily engaged in medicine manufacturing and sales. Pharmicell generates revenue through its biopharmaceutical division, selling stem cell therapeutic drugs and cosmetics, as well as stem cell storage services and MSCs for research. The fashion business contributes through the sale of apparel under the Religion and Day brands. The primary buyers for pharmaceutical products include healthcare providers and research institutions, while the fashion segment targets consumers purchasing women’s and men’s clothing. The company’s segments are biopharmaceuticals, stem cell services, and fashion apparel. The biopharmaceutical business develops and manufactures stem cell-based drugs and cosmetics, with MSCs used in research areas. The fashion segment operates under the brand names Religion and Day, providing women’s and men’s apparel. The company’s revenue streams are derived from the sale of therapeutic drugs, cosmetics, stem cell storage, MSCs for research, and apparel sales. The merged subsidiary’s medicine manufacturing and sales activity complements the core biopharmaceutical operations. Pharmicell Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharmicell Co stock

Free Cash Flow per Share of Pharmicell Co is 559.90 KRW in 2025.

Free Cash Flow per Share of Pharmicell Co changed from -14.01 KRW to 559.90 KRW, representing a -4,095.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Pharmicell Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Pharmicell Co

All Key Metrics — Pharmicell Co